“Our lab focus is on how vascular inflammation contributes to lung and lymphatic disease and to develop targeted therapeutics that can safely treat these conditions.” - Mark Nicolls
Research Areas
Lymphedema
Our group investigates the so-called 'third circulation', the lymphatics.
Our group recently found that loss of endothelial cell (EC) hypoxia inducible factor-2α (HIF-2α), induced by cigarette smoke, plays a key role in the development of emphysema.
